Trump: Most-Favored-Nation Drug Pricing Being Extended to State Medicaid Programs

President Donald Trump announced Friday that most-favored-nation pricing on prescription drugs negotiated in pharmaceutical company deals would be extended to Medicaid programs across all 50 states, Washington DC, and Puerto Rico. The extension applies to drug prices established through agreements Trump previously negotiated with pharmaceutical manufacturers.

Next story